Immunome Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunome Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Immunome Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.52M, a 1350% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.52M +$2.35M +1350% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.46M +$1.23M +534% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.56M +$1.28M +451% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $345K +$174K +102% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $174K -$8K -4.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $230K +$40K +21.1% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $284K -$216K -43.2% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $171K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $182K Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $190K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $500K Jan 1, 2022 10-K 2023-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.